{
  "ticker": "CVAC",
  "company_name": "CureVac N.V.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05960097",
      "title": "A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "SARS-CoV-2, COVID-19",
      "start_date": "2023-08-01",
      "completion_date": "2024-08-30",
      "enrollment": 0,
      "sponsor": "GlaxoSmithKline"
    },
    {
      "nct_id": "NCT03291002",
      "title": "Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC",
      "status": "UNKNOWN",
      "phase": "PHASE1",
      "condition": "Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Adenoid Cystic",
      "start_date": "2017-09-25",
      "completion_date": "2023-02",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT02241135",
      "title": "RNActive\u00ae Rabies Vaccine (CV7201) in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Rabies",
      "start_date": "2013-10",
      "completion_date": "2018-02-08",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT04674189",
      "title": "A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Coronavirus, Covid19, SARS-CoV-2, Severe Acute Respiratory Syndrome",
      "start_date": "2020-12-23",
      "completion_date": "2022-06-08",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT05252338",
      "title": "A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Influenza",
      "start_date": "2022-02-07",
      "completion_date": "2022-09-27",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT03203005",
      "title": "IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Hepatocellular Carcinoma",
      "start_date": "2017-09-18",
      "completion_date": "2019-12-20",
      "enrollment": 0,
      "sponsor": "National Cancer Institute, Naples"
    },
    {
      "nct_id": "NCT05938387",
      "title": "Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Glioblastoma",
      "start_date": "2023-06-01",
      "completion_date": "2026-02-04",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT01915524",
      "title": "Trial of RNActive\u00ae-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Non-Small Cell Lung Carcinoma",
      "start_date": "2013-04",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "CureVac"
    },
    {
      "nct_id": "NCT03164772",
      "title": "Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Metastatic Non-small Cell Lung Cancer, NSCLC",
      "start_date": "2017-12-20",
      "completion_date": "2021-10-29",
      "enrollment": 0,
      "sponsor": "Ludwig Institute for Cancer Research"
    },
    {
      "nct_id": "NCT02238756",
      "title": "Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Rabies",
      "start_date": "2014-09",
      "completion_date": "2016-11",
      "enrollment": 0,
      "sponsor": "CureVac"
    }
  ],
  "summary": {
    "total_trials": 26,
    "by_phase": {
      "PHASE2": 3,
      "PHASE1": 11,
      "PHASE3": 4,
      "PHASE1, PHASE2": 7,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 16,
      "UNKNOWN": 1,
      "ACTIVE_NOT_RECRUITING": 1,
      "TERMINATED": 5,
      "WITHDRAWN": 2,
      "NOT_YET_RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 16,
    "conditions": [
      "COVID-19, SARS-CoV-2",
      "Coronavirus, Covid19, SARS-CoV-2, Severe Acute Respiratory Syndrome",
      "Covid19, SARS-CoV-2",
      "Glioblastoma",
      "Hepatocellular Carcinoma",
      "Hormonal Refractory Prostate Cancer",
      "Hormone Refractory Prostate Cancer",
      "Influenza",
      "Influenza, Human",
      "Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Adenoid Cystic",
      "Metastatic Non-small Cell Lung Cancer, NSCLC",
      "Non Small Cell Lung Cancer",
      "Non-Small Cell Lung Carcinoma",
      "Prostate Cancer",
      "Prostate Carcinoma",
      "Rabies",
      "SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19)",
      "SARS-CoV-2, COVID-19",
      "Severe Acute Respiratory Syndrome, Coronavirus, SARS-CoV-2, COVID-19",
      "Squamous NSCLC"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:53.186285",
    "search_query": "CureVac N.V.",
    "url": "https://clinicaltrials.gov/search?term=CureVac+N.V."
  }
}